ABSTRACT
OBJECTIVE: Since the guidelines of the International Committee for Standardisation in Haematology (ICSH) in 1984 and those of the European Committee for External Quality Assessment Programmes in Laboratory Medicine (EQALM) in 2004, no leading organisation has published technical recommendations for the preparation of air-dried cytological specimens using May-Grünwald-Giemsa (MGG) staining. DATA SOURCES: Literature data were retrieved using reference books, baseline-published studies, articles extracted from PubMed/Medline and Google Scholar, and online-available industry datasheets. RATIONALE: The present review addresses all pre-analytical issues concerning the use of Romanowsky's stains (including MGG) in haematology and non-gynaecological cytopathology. It aims at serving as actualised, best practice recommendations for the proper handling of air-dried cytological specimens. It, therefore, appears complementary to the staining criteria of the non-gynaecological diagnostic cytology handbook edited by the United Kingdom National External Quality Assessment Service (UK-NEQAS) in February 2015.
Subject(s)
Cytodiagnosis , Hematology/methods , Staining and Labeling , Eosine Yellowish-(YS)/chemistry , France , Guidelines as Topic , Hematology/standards , Humans , Methylene Blue/chemistry , Quality Assurance, Health Care , United KingdomABSTRACT
OBJECTIVE: To analyze the cervical cytologic smear history of women with carcinoma in situ (CIS). STUDY DESIGN: We examined cytologic smears obtained within the three-year period prior to a histologic diagnosis of CIS in 585 women for whom at least one prebiopsy smear was available. RESULTS: Among 454 patients with only one smear available for review, 9 (2%) had a negative cytologic diagnosis, 58 (13%) had low grade squamous intraepithelial lesion (LSIL), and 387 (85%) had high grade squamous intraepithelial lesion (HSIL). One hundred thirty-one women had two to five smears taken within the previous three years available for review. All the smears taken prior to biopsy showed HSIL. The original diagnosis on the other smears was negative for 78 women (60%), HSIL for 46 (35%) and LSIL for 7 (5%). ALl 132 smears originally classified as negative from 87 of 585 (14.8%) women were reviewed. Twenty-seven (20%) were then classified as showing HSIL, 10 as LSIL, 10 as atypical squamous cells of undetermined significance, 7 as unsatisfactory and 78 (59%) as remaining negative. CONCLUSION: Of smears classified as negative and taken in the three years before biopsy-proven CIS, 41% were reclassified, with half reclassified as showing HSIL.
